PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Neurology, University of Alabama at Birmingham, AL, United States; Epilepsy and Cognitive Neurophysiology Laboratory, University of Alabama at Birmingham, AL, United States. Electronic address: spati@uabmc.edu.\', \'Department of Neurology, University of Alabama at Birmingham, AL, United States; Epilepsy and Cognitive Neurophysiology Laboratory, University of Alabama at Birmingham, AL, United States.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0920-1211(20)30230-810.1016/j.eplepsyres.2020.106399
?:doi
?:hasPublicationType
?:journal
  • Epilepsy research
is ?:pmid of
?:pmid
?:pmid
  • 32559589
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.956
?:rankingScore_hIndex
  • 104
is ?:relation_isRelatedTo_publication of
?:title
  • Assessing the risk of seizures with chloroquine or hydroxychloroquine therapy for COVID-19 in persons with epilepsy.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all